Search results
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
Zacks via Yahoo Finance· 1 month agoGSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month...
Honeywell (HON), Recipharm Unite to Develop Near-Zero GWP pMDIs
Zacks via Yahoo Finance· 8 months agoHoneywell International Inc. HON recently partnered with global contract development and...
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
Investor's Business Daily· 1 year agoSanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...
These 2022 Winning Stocks Can Keep Soaring in 2023, Say Analysts
TipRanks via Yahoo Finance· 1 year agoSeesaw trading and mixed messages – that’s been the market’s pattern for the past few weeks, and...
Climate change among factors that can worsen symptoms for asthma sufferers
The Columbus Dispatch via Yahoo News· 2 years agoTwenty-two years ago, Richard Tovar had his first asthma attack. He remembered that day in 2000...
Theravance's (TBPH) Q2 Earnings Beat, Focus on Pipeline
Zacks via Yahoo Finance· 2 years agoTheravance Biopharma, Inc. TBPH reported adjusted loss (excluding restructuring and related...
GSK Gears Up to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoGSK plc. GSK will report first-quarter 2023 results on Apr 26, before the opening bell. In the last...
GSK Gears Up for Q4 Earnings: Will It Surpass Estimates?
Zacks via Yahoo Finance· 3 months agoWe expect GSK plc. GSK to beat expectations when it reports fourth-quarter and full-year 2023...
Reasons Why You Should Add AptarGroup (ATR) to Your Portfolio
Zacks via Yahoo Finance· 7 months agoAptarGroup, Inc. ATR has been gaining from its focus on business transformation plans and improved...
Theravance (TBPH) Q3 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo Finance· 1 year agoTheravance Biopharma, Inc. TBPH reported third-quarter 2022 net loss of 21 cents per share, narrower...